Mark A Stein Selected Research

Mark A Stein Research Topics

Disease

45	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2022 - 04/2003
1	Sluggish Cognitive Tempo 03/2018
1	Autism Spectrum Disorder 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Brain Diseases (Brain Disorder) 12/2009
1	Schizophrenia (Dementia Praecox) 12/2009
1	Alzheimer Disease (Alzheimer's Disease) 12/2009
1	Substance-Related Disorders (Drug Abuse) 08/2007
1	Mood Disorders (Mood Disorder) 04/2003
1	Mental Disorders (Mental Disorder) 04/2003

Drug/Important Bio-Agent (IBA)

17	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 11/2003
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2015
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2014 - 07/2005
4	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 07/2017 - 08/2007
3	Pharmaceutical PreparationsIBA 01/2019 - 02/2010
3	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019 - 12/2011
3	Dexmethylphenidate Hydrochloride FDA LinkGeneric 06/2014 - 08/2007
2	gamma-Aminobutyric Acid (GABA)IBA 04/2022 - 01/2021
2	Dopamine Agents (Dopaminergic Agents)IBA 07/2017 - 01/2007
2	Guanfacine (Tenex)FDA LinkGeneric 11/2015 - 09/2013
2	SaltsIBA 06/2014 - 12/2011
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2010 - 02/2010
2	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2010 - 09/2007
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 02/2010 - 12/2009
2	CatecholaminesIBA 12/2009 - 04/2008
1	Glutamic Acid (Glutamate)FDA Link 04/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Lisdexamfetamine Dimesylate FDA Link 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2015
1	tyramine-deoxysorbitolIBA 01/2015
1	TEMPOIBA 09/2013
1	Synaptosomal-Associated Protein 25IBA 02/2010
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 02/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 02/2010
1	Dopamine (Intropin)FDA LinkGeneric 02/2010
1	EnzymesIBA 02/2010
1	Cholinergic AgonistsIBA 12/2009
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	Cholinergic Agents (Cholinergics)IBA 12/2009
1	choline transporterIBA 12/2009
1	Controlled SubstancesIBA 08/2007
1	Homovanillic AcidIBA 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	Thyroid HormonesIBA 04/2003
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2003

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2008
3	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
2	Precision Medicine 01/2022 - 01/2021
1	Medical Day Care (Partial Hospitalization) 12/2022
1	Treatment Delay 01/2021
1	Duration of Therapy 01/2020
1	Aftercare (After-Treatment) 01/2019